Add time:08/21/2019 Source:sciencedirect.com
Objectives and AimIn this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and LENOGRASTIM (cas 135968-09-1) (Granocyte®) on CD34+ cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).
We also recommend Trading Suppliers and Manufacturers of LENOGRASTIM (cas 135968-09-1). Pls Click Website Link as below: cas 135968-09-1 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View